文献速递复苏、休克与脓毒症重症综合管理与镇静镇痛

血管生成素-2作为脓毒症成人患者预后生物标志物:系统评价与Meta分析

Angiopoietin-2 as a prognostic biomarker in septic adult patients: a systemic review and meta-analysis.
PubMed 文献 · Ann Intensive Care · 2024-11-10
一句话结论Meta分析显示脓毒症成人患者中血管生成素-2水平与死亡风险正相关,可能有助于预测死亡。

该系统评价与Meta分析共纳入33项研究、4703例参与者,检索PubMed、Cochrane Library、Embase、万方、CNKI、维普和CBM数据库至2023年7月16日,采用纽卡斯尔-渥太华量表(NOS)评估质量。非存活者血管生成素-2(Ang-2)水平较存活者显著升高(SMD=1.08,95%CI 0.68-1.49,P<0.001),在符合脓毒症3.0诊断标准的亚组中同样升高(SMD=0.63,95%CI 0.11-1.14,P=0.017)。Ang-2是死亡的危険因素(OR=1.16,95%CI 1.09-1.23,P<0.001),预测脓毒症成人患者死亡的AUC=0.76(95%CI 0.70-0.82,P<0.001)。作者认为Ang-2水平与脓毒症患者死亡风险正相关,可能是预测脓毒症成人患者死亡的有用且有价值的生物标志物。

要点

  • 非存活者Ang-2水平较存活者显著升高(SMD=1.08,95%CI 0.68-1.49,P<0.001),符合脓毒症3.0诊断标准的亚组同样升高(SMD=0.63,95%CI 0.11-1.14,P=0.017)。
  • Ang-2是脓毒症患者死亡的危険因素(OR=1.16,95%CI 1.09-1.23,P<0.001)。
  • Ang-2预测脓毒症成人患者死亡的AUC=0.76(95%CI 0.70-0.82,P<0.001)。
  • 非存活者与存活者Ang-2水平的比较结果不受随访时长、样本来源、研究类型和地区的影响。
  • 作者认为Ang-2可能是预测脓毒症成人患者死亡的有用且有价值的生物标志物。

适用人群与场景

  • 脓毒症成人患者(纳入研究中符合脓毒症3.0诊断标准的亚组亦单独分析)

研究设计与关键结果

  • 研究类型:系统评价与Meta分析,最终纳入33项研究、4703例参与者;检索PubMed、Cochrane Library、Embase、万方、CNKI、维普和CBM数据库至2023年7月16日。
  • 质量评估:根据纽卡斯尔-渥太华量表(NOS),1项研究为中等质量,其余为高质量。
  • 主要结果:非存活者Ang-2水平较存活者显著升高(SMD=1.08,95%CI 0.68-1.49,P<0.001);符合脓毒症3.0诊断标准的亚组中同样升高(SMD=0.63,95%CI 0.11-1.14,P=0.017)。
  • 亚组/敏感性:非存活者与存活者Ang-2水平的比较结果不受随访时长、样本来源、研究类型和地区的影响。
  • 预后价值:Ang-2是死亡的危険因素(OR=1.16,95%CI 1.09-1.23,P<0.001);预测脓毒症成人患者死亡的AUC=0.76(95%CI 0.70-0.82,P<0.001)。

证据类型、等级与局限

  • 证据类型:系统评价与Meta分析(纳入33项研究,4703例参与者)。
  • 质量评估:采用纽卡斯尔-渥太华量表(NOS),1项研究为中等质量,其余为高质量。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为Ang-2可能是预测脓毒症成人患者死亡的有用且有价值的生物标志物。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: The impairment of endothelial function represents a key pathophysiological mechanism in the development of sepsis. This research aimed to evaluate the prognostic significance of angiopoietin-2 (Ang-2), an endothelial biomarker, in predicting mortality in sepsis patients.

METHODS: Chinese and English studies were systematically retrieved in PubMed, Cochrane Library, Embase, WanFang, CNKI, CQVIP, and CBM databases up to July 16, 2023. We conducted a study selection established upon predefined inclusion and exclusion criteria and used the Newcastle-Ottawa scale (NOS) to assess its quality. We extracted available data from the included studies for data analysis.

RESULTS: The final inclusion comprised 33 studies with 4703 participants. According to the NOS, one study was of medium quality, while the rest were of high quality. In comparison to survivors, the levels of Ang-2 in non-survivors were markedly elevated [standardized mean difference (SMD) = 1.08, 95% confidence intervals (CI) 0.68-1.49, P < 0.001], and the same results were also observed in the subgroup that met sepsis 3.0 diagnosis criteria (SMD = 0.63, 95% CI 0.11-1.14, P = 0.017). The results comparing Ang-2 levels between non-survivors and survivors were independent of duration of follow-up, sample sources, type of study, and region. Ang-2 was a risk factor for mortality [odds ratios (OR) = 1.16, 95% CI 1.09-1.23, P < 0.001]. Ang-2 was demonstrated to be able to predict mortality in septic adult patients [area under the curve (AUC) = 0.76, 95% CI 0.70-0.82, P < 0.001].

CONCLUSIONS: Ang-2 level was positively correlated with risk of death in sepsis patients. Ang-2 might be a useful and valuable biomarker for predicting mortality in septic adult patients.

来源:Ann Intensive Care,查看原文。版权归原作者所有。

参考来源

  1. Zhuo M, Fu S, Chi Y, et al. Angiopoietin-2 as a prognostic biomarker in septic adult patients: a systemic review and meta-analysis. Ann Intensive Care. 2024. PMID: 39522088. doi:10.1186/s13613-024-01393-0

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。